Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573961 | SCV000675472 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704689 | SCV000730272 | likely benign | not provided | 2020-08-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000644346 | SCV000766039 | likely benign | Tuberous sclerosis 2 | 2024-11-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000644346 | SCV002041367 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573961 | SCV002530979 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-07 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV004001144 | SCV004819296 | likely benign | Tuberous sclerosis syndrome | 2023-10-02 | criteria provided, single submitter | clinical testing |